Is Apollo Hospitals Enterprise the Best Stock in Its Sector? A Look at the Numbers
- October 13, 2026
- Posted by: Harsh Piplani
- Category: Market
Apollo Hospitals Enterprise CMP Rs 8,074 (12 Oct 2026). Market cap Rs 1,15,315 Cr. ROE 20.48%. P/E 53.09x versus Industry P/E 62.56x.
Quick Answer
Apollo Hospitals Enterprise is one of the names investors compare when screening the Healthcare sector, built on a 20.48% return on equity and a P/E of 53.09x against an Industry P/E of 62.56x. Whether Apollo Hospitals Enterprise is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is Apollo Hospitals Enterprise the best stock in its sector? The stock trades on the NSE at Rs 8,074 as of 12 October 2026, within its 52-week range of Rs 6,696.50 to Rs 9,070.50. Apollo Hospitals Enterprise Ltd, headquartered in Chennai, is one of India’s largest private hospital chains, and also runs pharmacy and healthcare services businesses.
Apollo Hospitals Enterprise sits in the Healthcare sector, and its 20.48% ROE and 53.09x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Apollo Hospitals Enterprise
Apollo Hospitals Enterprise Ltd, headquartered in Chennai, is one of India’s largest private hospital chains, and also runs pharmacy and healthcare services businesses. Hospitals, pharmacy and diagnostics-linked services sit under one group. The stock trades about 11 percent below its 52-week high and about 21 percent above its 52-week low. At a market capitalisation of Rs 1,15,315 Cr, it is tracked as part of the Healthcare sector on Univest.
Is Apollo Hospitals Enterprise the Best Stock in Its Sector?
Apollo Hospitals Enterprise makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 20.48% ROE with a 53.09x P/E against the sector’s 62.56x Industry P/E. Apollo Hospitals’ 53.09x P/E is below the 62.56x Industry P/E, supported by a 20.48% ROE, though a 12.16 P/B and a debt to equity ratio of 0.90 are worth weighing.
| Metric | Apollo Hospitals Enterprise |
|---|---|
| CMP (NSE) | Rs 8,073.50 |
| 52-Week High / Low | Rs 9,070.50 / Rs 6,696.50 |
| Market Cap | Rs 1,15,315 Cr |
| P/E (TTM) vs Industry P/E | 53.09x vs 62.56x |
| P/B | 12.16 |
| ROE | 20.48% |
| EPS (TTM) | Rs 151.06 |
| Dividend Yield | 0.25% |
| Debt to Equity | 0.90 |
Compare Apollo Hospitals Enterprise Against Other Healthcare Sector Stocks
How Apollo Hospitals Enterprise Compares Against Its Healthcare Sector Peers
The table below sets Apollo Hospitals Enterprise against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | 1,15,315 | 53.09 | 20.48% | 0.90 |
| Max Healthcare Institute | 86,041 | 59.05 | 13.42% | 0.32 |
| Fortis Healthcare | 59,272 | 55.37 | 10.53% | 0.35 |
| Peer average (2 companies) | – | 57.21 | 11.97% | 0.33 |
Against this peer set, Apollo Hospitals Enterprise’s 20.48% ROE is above the 11.97% peer average, and its P/E of 53.09x runs below the peer average of 57.21x. Apollo Hospitals’ 53.09x P/E is below the 62.56x Industry P/E, supported by a 20.48% ROE, though a 12.16 P/B and a debt to equity ratio of 0.90 are worth weighing.
What Makes Apollo Hospitals Enterprise Worth Watching in Healthcare
- Discount to sector: A 53.09x P/E sits below the 62.56x Industry P/E.
- Strong returns: A 20.48% ROE is higher than both hospital peers shown here.
- Leverage: A debt to equity ratio of 0.90 is higher than Max Healthcare’s 0.32 in the peer table.
Apollo Hospitals Enterprise Valuation: Is It Justified?
Apollo Hospitals’ 53.09x P/E is below the 62.56x Industry P/E, supported by a 20.48% ROE, though a 12.16 P/B and a debt to equity ratio of 0.90 are worth weighing. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Lupin the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Apollo Hospitals Enterprise and other Healthcare sector stocks.
How to Track Apollo Hospitals Enterprise Before You Invest
Before deciding whether Apollo Hospitals Enterprise deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for Apollo Hospitals Enterprise to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Apollo Hospitals Enterprise earns a place in the best stock in its sector conversation on the strength of a 20.48% ROE and a P/E of 53.09x against a 62.56x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Apollo Hospitals Enterprise the best stock in its sector?
Ans. Apollo Hospitals Enterprise has a 20.48% ROE and trades at 53.09x P/E against a 62.56x Industry P/E, and compares above the peer average ROE of 11.97% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Apollo Hospitals Enterprise?
Ans. Apollo Hospitals Enterprise was trading at Rs 8,073.50 on the NSE as of 12 October 2026, within its 52-week range of Rs 6,696.50 to Rs 9,070.50.
What sector does Apollo Hospitals Enterprise belong to?
Ans. Apollo Hospitals Enterprise is classified under the Healthcare sector on Univest.
How does Apollo Hospitals Enterprise compare to its sector peers on P/E?
Ans. Apollo Hospitals Enterprise’s P/E of 53.09x is below the 57.21x average of the 2 named peers compared in this article.
What is Apollo Hospitals Enterprise’s return on equity?
Ans. Apollo Hospitals Enterprise reported a return on equity of 20.48%, which is above the 11.97% average of its named peers in this comparison.
Should I invest in Apollo Hospitals Enterprise based on its sector position?
Ans. Apollo Hospitals Enterprise’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
